Literature DB >> 23532120

Pre- and postoperative lower extremity motor power and ambulatory status of patients with spinal cord compression due to a metastatic spinal tumor.

Jin Hoon Park1, Sang Ryong Jeon.   

Abstract

STUDY
DESIGN: Retrospective review of medical records.
OBJECTIVE: To describe pre- and postoperative ambulatory status and lower limb motor power, and compare characteristics of patients with metastatic spinal cord compression (MSCC) who were ambulatory at 48 hours postoperatively with those of patients with MSCC who were nonambulatory. SUMMARY OF BACKGROUND DATA: Preoperative motor power of the lower extremities is a predictor of postoperative ambulatory status in patients with MSCC.
METHODS: We retrospectively evaluated the medical records of 102 consecutive patients with MSCC who presented for decompressive surgery with lower extremity weakness between January 1997 and December 2010. A single surgeon classified the preoperative and 48-hour postoperative motor power of the lower extremities on a 6-point scale. Ambulation status was determined 48 hours after surgery and patients were classified as ambulatory (including normal ambulation, ambulation with aid, and ambulation without aid) or nonambulatory. Demographic and clinical characteristics were compared between patients who were ambulatory and those who were nonambulatory at 48 hours postoperatively.
RESULTS: Motor power was improved 1.05 ± 0.73 grades after operation. Two-thirds of patients who were preoperatively classified as nonambulatory were ambulatory at 48 hours postoperatively. The only significantly different affecting factor between the postoperative ambulatory group and the nonambulatory group was preoperative lower extremity power and preoperative capability of ambulation. In addition, grade III of lower extremity motor power was significant criteria for postoperative ambulation.
CONCLUSION: We recommend aggressive decompressive surgery in patients with MSCC if preoperative lower extremity motor power is at least grade III, although all groups of preoperative lower extremity motor power had 1 or more patients who returned to ambulation. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2013        PMID: 23532120     DOI: 10.1097/BRS.0b013e3182927559

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  12 in total

1.  Metastasectomy and Targeted Therapy for Patients With Spinal Metastases of Renal Cell Carcinoma.

Authors:  Dmitrii Ptashnikov; Nikita Zaborovskii; Stanislav Kostrickii; Dmitrii Mikaylov; Sergei Masevnin; Oleg Smekalenkov; Irakli Kuparadze
Journal:  Int J Spine Surg       Date:  2020-12-29

2.  Long-term survivors after surgical management of metastatic spinal cord compression.

Authors:  Emeline Tabouret; G Gravis; C Cauvin; A Loundou; T Adetchessi; S Fuentes
Journal:  Eur Spine J       Date:  2014-11-19       Impact factor: 3.134

Review 3.  A systematic review of MIS and open decompression surgery for spinal metastases in the last two decades.

Authors:  Bhoresh Dhamija; Dheeraj Batheja; Birender Singh Balain
Journal:  J Clin Orthop Trauma       Date:  2021-09-25

4.  Preoperative prediction for regaining ambulatory ability in paretic non-ambulatory patients with metastatic spinal cord compression.

Authors:  M Ohashi; T Hirano; K Watanabe; K Katsumi; H Shoji; A Sano; H Tashi; I Takahashi; M Wakasugi; Y Shibuya; N Endo
Journal:  Spinal Cord       Date:  2016-10-18       Impact factor: 2.772

5.  Malignant rhabdoid tumor of the kidney and spine in an infant.

Authors:  Sejun Park; Jae-Hee Seo; Jun Bum Park; Sungchan Park
Journal:  J Korean Neurosurg Soc       Date:  2014-01-31

6.  Functional and survival outcomes in patients undergoing surgical treatment for metastatic disease of the spine.

Authors:  Vignesh K Alamanda; Myra M Robinson; Jeffrey S Kneisl; Joshua C Patt
Journal:  J Spine Surg       Date:  2018-03

Review 7.  Predicting Neurologic Recovery after Surgery in Patients with Deficits Secondary to MESCC: Systematic Review.

Authors:  Ilya Laufer; Scott L Zuckerman; Justin E Bird; Mark H Bilsky; Áron Lazáry; Nasir A Quraishi; Michael G Fehlings; Daniel M Sciubba; John H Shin; Addisu Mesfin; Arjun Sahgal; Charles G Fisher
Journal:  Spine (Phila Pa 1976)       Date:  2016-10-15       Impact factor: 3.241

Review 8.  Evaluating ambulatory function as an outcome following treatment for spinal metastases: a systematic review.

Authors:  Lananh Nguyen; Nicole Agaronnik; Marco L Ferrone; Jeffrey N Katz; Andrew J Schoenfeld
Journal:  Spine J       Date:  2021-05-13       Impact factor: 4.297

9.  Metastatic spinal cord compression (MSCC) treated with palliative decompression: Surgical timing and survival rate.

Authors:  Wan-Yu Lo; Shu-Hua Yang
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240

Review 10.  An Overview of Decision Making in the Management of Metastatic Spinal Tumors.

Authors:  Gautam R Zaveri; Reetu Jain; Nishank Mehta; Bhavuk Garg
Journal:  Indian J Orthop       Date:  2021-03-06       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.